Device type · OBH
Monitor, Extracellular Fluid, Lymphedema, Extremity
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
OBH
Gastroenterology & Urology
Device class
Class II
FDA decisions since 2015
7
510(k), De Novo and PMA
Adverse event reports
1
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Monitor, Extracellular Fluid, Lymphedema, Extremity
- Product code
- OBH
- Device class
- Class II
- Review panel
- Gastroenterology & Urology
- Regulation
- 21 CFR 870.2770
- Specialty
- GI, Urology & Nephrology
- FDA record
- Classification database entry for OBH
Latest FDA decisions
K261628 · Decided Oct 28, 2026 · 166 days after receipt
Device type: Monitor, Extracellular Fluid, Lymphedema, Extremity (OBH) · Cardiology
K253224 · Decided Jan 28, 2026 · 121 days after receipt
Device type: Monitor, Extracellular Fluid, Lymphedema, Extremity (OBH) · Cardiology
- SOZO Pro510(k)
K230530 · Decided May 4, 2023 · 66 days after receipt
Device type: Monitor, Extracellular Fluid, Lymphedema, Extremity (OBH) · Cardiology
4 more FDA decisions with a free account
Reports received
1
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
1
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 1 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Improper or Incorrect Procedure or Method1
- Incorrect, Inadequate or Imprecise Result or Readings1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Swelling/ Edema1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- SOZO Bilateral Arm L-Dex SoftwareOpen, Classified
Z-0155-2024 · Started Aug 17, 2023 · Posted by FDA Oct 24, 2023
Reason given: Bilateral L-Dex assessment software does not have the same level of sensitivity to help detect early signs of lymphedema as the unilateral arm L-Dex assessment, which could result in under-recognition of early lymphedema, which could result in delay in early intervention, and more aggressive intervention.
Cause as FDA categorized it: Device Design
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.